Multi-center Study Demonstrates Significant Reductions in Postoperative Pain and Opioid Use Following Peripheral Nerve Stimulation Treatment
April 26, 2021 09:41 ET
|
SPR Therapeutics, Inc.
CLEVELAND, April 26, 2021 (GLOBE NEWSWIRE) -- Results of a multicenter trial recently published in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists,...
Researchers Unveil a New Theory Explaining Long-term Pain Relief
March 15, 2021 09:30 ET
|
SPR Therapeutics, Inc.
CLEVELAND, March 15, 2021 (GLOBE NEWSWIRE) -- A novel theory recently published in the Journal of Pain Research proposes mechanisms by which a 60-day treatment using percutaneous peripheral nerve...
SPRINT® PNS System Demonstrates the Important Role of the Multifidus in Treating Recurrent Low Back Pain Following RFA
March 02, 2021 10:45 ET
|
SPR Therapeutics, Inc.
CLEVELAND, March 02, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of...
SPR Therapeutics’ CEO Maria Bennett Named as an Entrepreneur Of The Year® 2020 East Central Award Finalist
August 31, 2020 12:25 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) today announced that Maria Bennett, President, CEO and Founder of SPR Therapeutics, Inc.® was named an Entrepreneur Of The...
Study of Sprint Peripheral Nerve Stimulation System Demonstrates 12 Months of Low Back Pain Relief Following 60-Day Treatment
January 21, 2020 08:55 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding...
Study Demonstrates 12-Month Relief of Post-Amputation Pain Following Treatment With SPRINT PNS System
December 10, 2019 08:29 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Dec. 10, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of 12-month follow up results of its...
SPR Therapeutics Announces 1000th Sprint PNS Procedure
December 04, 2019 08:30 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th...
SPR Therapeutics’ SPRINT Peripheral Nerve Stimulation System Significantly Reduces Opioid Use in Patients with Low Back Pain, Interim Data Show
August 21, 2019 08:30 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Ohio and KISSIMMEE, Florida, Aug. 21, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, presented interim results today on the...
Study of SPR Therapeutics’ Peripheral Nerve Stimulation System Demonstrates Significant and Sustained Relief of Post-Amputation Pain
April 08, 2019 13:39 ET
|
SPR Therapeutics, Inc.
CLEVELAND, April 08, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced the results of a study of its SPRINT® Peripheral...
SPR Therapeutics Names Dr. Peter Staats as Chief Medical Advisor
January 15, 2019 10:00 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Jan. 15, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Peter Staats, MD, MBA, has been named Chief...